Clinical Trials: Lowereing A1C, Weight Change & CV Data

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

Comparing the Effects of Consuming Almonds or Biscuits on Body Weight in Habitual Snackers: A 1-Year Randomized Controlled Trial - The American Journal of Clinical Nutrition

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP

Clinical Trials: Lowereing A1C, Weight Change & CV Data

1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study

Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention

Hemoglobin A1c Reduction and CV Risk Improvement: Correlation, Causation and Clinical Recommendations

Cureus, Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond

Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators

Weight loss and benefits for cardiovascular disease (CVD)

PDF) Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeks

A) Baseline-adjusted mean change in HbA1c from baseline to week 52. B)

A Review of the Glycemia Reduction Approaches in Diabetes (GRADE) Study: Comparing the Effectiveness of Type 2 Diabetes Medications

A1C and Weight Change Results

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential